Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-20 4:23 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Rosalind Advisors Inc. | 969,484 6.5% | 156,929 (+19.31%) | View |
| 2022-01-20 4:21 pm Purchase | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 553,290 8.1% | 187,390 (+51.21%) | View |
| 2022-01-06 8:15 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Rosalind Advisors Inc. | 653,438 5% | 653,438 (New Position) | View |
| 2021-09-23 4:54 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Rosalind Advisors Inc. | 812,555 5.6% | 812,555 (New Position) | View |
| 2021-07-08 1:30 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 3,207,160 6% | 3,207,160 (New Position) | View |
| 2021-06-25 5:20 pm Sale | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,253,958 9.9% | -713,542 (-36.27%) | View |
| 2021-05-19 2:25 pm Purchase | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Rosalind Advisors Inc. | 2,607,857 5.4% | 2,607,857 (New Position) | View |
| 2021-05-19 1:37 pm Purchase | 13G | MYOMO INC MYO | Rosalind Advisors Inc. | 365,900 6.5% | 365,900 (New Position) | View |
| 2021-04-06 10:01 am Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,967,500 9.9% | 0 (Unchanged) | View |
| 2021-01-22 5:26 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Rosalind Advisors Inc. | 5,377,113 4.8% | 1,377,113 (+34.43%) | View |
| 2021-01-22 5:26 pm Unchanged | 13G | PLX PHARMA INC PLXP | Rosalind Advisors Inc. | 970,425 6.7% | 0 (Unchanged) | View |
| 2020-12-17 7:09 pm Purchase | 13G | PLX PHARMA INC PLXP | Rosalind Advisors Inc. | 970,425 6.7% | 970,425 (New Position) | View |
| 2020-09-18 4:56 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Rosalind Advisors Inc. | 4,000,000 5.4% | 4,000,000 (New Position) | View |
| 2020-05-13 9:33 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 1,967,500 9.9% | 1,113,550 (+130.40%) | View |
| 2020-04-09 7:13 pm Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 853,950 9.9% | 0 (Unchanged) | View |
| 2020-03-11 7:41 pm Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 853,950 9.9% | 0 (Unchanged) | View |
| 2020-03-06 4:22 pm Purchase | 13G | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 853,950 9.9% | 853,950 (New Position) | View |
| 2020-02-13 4:00 pm Sale | 13G | DELCATH SYS INC PAR $0.01 DCTH | Rosalind Advisors Inc. | 468,452 9.9% | -279,531,548 (-99.83%) | View |
| 2019-08-01 4:21 pm Purchase | 13G | DELCATH SYS INC PAR $0.01 DCTH | Rosalind Advisors Inc. | 280,000,000 9.9% | 280,000,000 (New Position) | View |
| 2019-07-24 4:53 pm Sale | 13G | CHIASMA INC CHMA | Rosalind Advisors Inc. | 936,651 2.9% | -1,066,827 (-53.25%) | View |